The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design.

Trial Profile

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Lovastatin; Niacin; Niacin/lovastatin
  • Indications Intermittent claudication
  • Focus Therapeutic Use
  • Acronyms TROPIC
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 08 Nov 2006 Status change
    • 08 Aug 2006 Status change
    • 14 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top